Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care.
JAMA. 2001;286(2):208-216.
Barrett B, Kiefer D, Rabago D. Assessing the risks and benefits of herbal
medicine: an overview of scientific evidence. Altern Ther Health Med.
1999;5(4):40-49.
Beaubrun G, Gray GE. A review of herbal medicines for psychiatric disorders.
Psychiatr Serv. 2000;51(9):1130-1134.
Biffignandi PM, Bilia AR. The growing knowledge of St. John's wort
(Hypericum perforatum L) drug interactions and their clinical
significance. Curr Ther Res. 2000;61(70):389-394.
Blumenthal M, Goldberg A, Brinckmann J. Herbal Medicine: Expanded
Commission E Monographs. Newton, MA: Integrative Medicine Communications;
2000:359-366.
Breidenbach T, Hoffmann MW, Becker T, Schlitt H, Klempnauer J. Drug
interaction with St. John's wort with cyclosporin. Lancet.
1000;355:576-577.
Breidenbach T, Kliem V, Burg M, Radermacher J, Hoffman MW, Klempnauer J.
Profound drop of cyclosporin A whole blood trough levels caused by St. John's
wort (Hypericum perforatum) [letter]. Transplantation.
2000;69(10):2229-2230.
Brenner R, Azbel V, Madhusoodanan S, Pawlowska M. Comparison of an extract of
hypericum (LI 160) and sertraline in the treatment of depression: a
double-blind, randomized pilot study. Clin Ther. 2000;22(4):411-419.
Brinker F. Herb Contraindications and Drug Interactions. 2nd ed.
Sandy, Ore: Eclectic Medical; 1998:123-125.
Carai MAM, Agabio R, Bombardelli E, et al. Potential use of medicinal plants
in the treatment of alcoholism. Fitoterapia. 2000;71:538-542.
De Smet P, Touw D. Safety of St. John's wort (Hypericum perforatum)
[letter]. Lancet. 2000;355:575-576.
Ernst E, Rand JI, Barnes J, Stevinson C. Adverse effects profile of the
herbal antidepressnat St. John's wort (Hypericum perforatum L.) Eur J
Clin Pharmacol. 1998;54:589-594.
Ernst E, Rand JI, Stevinson C. Complementary therapies for depression.
Arch Gen Psychiatry. 1998;55:1026-1032.
Ernst E. Herbal medications for common ailments in the elderly. Drugs
& Aging. 1999;6:423-428.
Ernst E. Second thoughts about safety of St John's wort. Lancet.
1999;354:2014-2015.
Food and Drug Administration. Risk of Drug Interactions with St John's
Wort and Indinavir and Other Drugs. Rockville, Md: National Press Office;
February 10, 2000. Public Health Advisory.
Foster S, Tyler VE. The Honest Herbal: A Sensible Guide to the Use of
Herbs and Related Remedies. New York, NY: The Haworth Herbal
Press;1999:331-333.
Fugh-Berman A, Cott JM. Dietary supplements and natural products as
psychotherapeutic agents. Psychosom Med. 1999;61:712-728.
Gaster B, Holroyd J. St. John's wort for depression. Arch Intern Med.
2000;160:152-156.
Gordon JB. SSRIs and St. John's Wort: possible toxicity? [letter] Am Fam
Physician. 1998;57(5):950,953.
Grush LR, Nierenberg A, Keefe B, Cohen LS. St. John's wort during pregnancy
[letter]. JAMA. 1998;280(18):1566.
Hubner W-D, Kirste T. Experience with St John's wort (Hypericum
perforatum) in children under 12 years with symptoms of depression and
psychovegetative disturbances. Phytother Res. 2001;15:367-370.
Hypericum Depression Trial Study Group. Effect of Hypericum perforatum
(St John's wort) in major depressive disorder: a randomized controlled trial.
JAMA. 2002;287:1807-1814.
Johne A, Brockmoller J, Bauer S, et al. Pharmacokinetic interaction of
digoxin with an herbal extract from St. John's wort (Hypericum
perforatum). Clin Pharmacol Ther. 1999;66:338-345.
Khawaja IS, Marotta RF, Lippmann S. Herbal medicines as a factor in delirium.
Psychiatr Serv. 1999;50:969-970.
Kim HL, Streltzer J, Goebert D. St. John's wort for depression: a
meta-analysis of well-defined clinical trials. J Nerv Ment Dis.
1999;187:532-539.
Lantz MS, Buchalter E, Giambanco V. St. John's wort and antidepressant drug
interactions in the elderly. J Geriatr Psychiatry Neurol.
1999;12(1):7-10.
Linde K, Mulrow CD. St. John's wort for depression (Cochrane Review). In: The
Cochrane Library, Issue 4, 2000. Oxford: Update Software.
Linde K, Ramirez G, Mulrow CD, Pauls A. Weidenhammer W, Melchart D. St.
John's wort for depression: an overview and meta-analysis of randomised clinical
trials. BMJ. 1996;313:253–257.
Martinez B, Kasper S, Ruhrmann S, Moller HJ. Hypericum in the treatment of
seasonal affective disorders. J Geriatr Psychiatry Neurol. 1994;7(Suppl
1):S29–33.
Miller LG. Herbal medicinals: selected clinical considerations focusing on
known or potential drug-herb interactions. Arch Intern Med.
1998;158(20):2200–2211.
Morelli V, Zoorob RJ. Alternative therapies: Part 1. Depression, diabetes,
obesity. Am Fam Phys. 2000;62(5):1051-1060.
Nebel A, Schneider BJ, Baker RK, et al. Potential metabolic interaction
between St. John's wort and theophylline. Ann Pharmacother.
1999;33:502.
Obach RS. Inhibition of human cytochrome P450 enzymes by consituents of St.
John's wort, an herbal preparation in the treatment of depression. J
Pharmacol Exp Ther. 2000;294(1):88-95.
O'Hara M, Kiefer D, Farrell K, Kemper K. A review of 12 commonly used
medicinal herbs. Arch Fam Med. 1998;7(6):523-536.
Ondrizek RR, Chan PJ, Patton WC, King A. An alternative medicine study of
herbal effects on the penetration of zona-free hamster oocytes and the integrity
of sperm deoxyribonucleic acid. Fertil Steril. 1999;71(3):517-522.
Phillipp M, Kohnen R, Hiller KO. Hypericum extract versus impramine or
placebo in patients with moderate depression: randomised multicentre study of
treatment for eight weeks. BMJ. 1999:319(7224):1534-1538.
Piscitelli S, Burstein AH, Chaitt D, et al. Indinavir concentrations and St.
John's wort [letter]. Lancet. 2000;355:547-548.
Pizzorno JE, Murray MT. Textbook of Natural Medicine. New York: Churchill
Livingstone; 1999:268-269, 797-804.
Rezvani AH, Overstreet DH, Yang Y, Calrk E. Attenuation of alcohol intake by
extract of Hypericum perforatum (St. John's wort) in two different
strains of alcohol-preferring rats. Alcohol Alcohol.
1999;34(5):699-705.
Robbers JE, Tyler V. Herbs of Choice: The Therapeutic Use of
Phytomedicinals. New York, NY: The Haworth Herbal Press; 1999:166-170.
Rotblatt M, Ziment I. Evidence-Based Herbal Medicine. Philadelphia,
Penn:Hanley & Belfus, Inc. 2002:315-321.
Ruschitzka F, Meier PJ, Turina M, et al. Acute heart transplant rejection due
to Saint John's wort [letter]. Lancet. 2000,355.
Sarrell EM, Mandelberg A, Cohen HA. Efficacy of naturopathic extracts in the
management of ear pain associated with acute otitis media. Arch Pediatr
Adolesc Med. 2001;155:796-799.
Schempp CM, Pelz K, Wittmer A, Schopf E, Simon JC. Antibacterial activity of
hyperforin from St. John's wort, against multireistant Staphylococcus aureus and
gram-positive bacteria. Lancet. [Research Letters]1999;353:2129.
Schempp CM, Winghofer B, Ludtke R, Simon-Haarhaus B, Shopp E, Simon JC.
Topical application of St John's wort (Hypericum perforatum L) and of its
metabolite hyperforin inhibits the allostimulatory capacity of epidermal cells.
Br J Derm. 2000;142:979-984.
Schrader E. Equivalence of St John's wort extract (Ze 117) and fluoxetine: a
randomized, controlled study in mild-moderate depression. Int Clin
Psychopharmacol. 2000;15(2):61-68.
Shelton RC, Keller MB, Gelenberg A, et al. Effectiveness of St. John's wort
in major depression: a randomized controlled trial. JAMA.
2001;285(15):1978-1986.
Stevinson C, Ernst E. A pilot study of Hypericum perforatum for the
treatment of premenstrual syndrome. British Journal of Obstetrics and
Gynaecology. 2000;107:870-876.
Volz HP, Laux P. Potential treatment for subthreshold and mild depression: a
comparison of St. John's wort extracts and fluoxetine. Comp Psych.
2000;41(2 Suppl 1):133-137.
White L, Mavor S. Kids, Herbs, Health. Loveland, Colo: Interweave
Press; 1998:22, 40.
Woelk H, for the Remotiv/Imipramine Study Group. Comparison of St. John's
wort and imipramine for treating depression: randomized controlled trial.
BMJ. 2000;321:536-539.
Wong AH,Smith M, Boon HS. Herbal remedies in psychiatric practice. Arch
Gen Psych. 1998;55(11):1033-1044.
Yue Q, Bergquist C, Gerden B. Safety of St. John's wort (Hypericum
perforatum) [letter]. Lancet. 2000;355:576-577.